News and updates from across the LGC Group

Colin Hill, Chief Commercial Officer at LGC’s Diagnostics and Genomics Division, talks about how the fundamentals of quality, usability and value matter more than ever, even as technologies evolve, markets expand and healthcare challenges become increasingly complex.

In August 2026, our Grant Management Group (GMG) colleagues hosted seven students from the Lewisham Youth Brain Health Project, funded by the Alzheimer’s Research UK Inspire Fund.

Reducing our impact on the environment is something that we have already committed to for the long term, and a key focus area is packaging.

The acquisition further enhances LGC’s ability to support pharmaceutical, food, and testing laboratories with trusted reference materials that underpin safety, quality, and regulatory confidence. 

Our mission Science for a Safer World remains at the heart of everything we do. Across our businesses, we provide the components, standards, and services that support scientific discovery, enable better health outcomes, and safeguard the integrity of food, medicines, and the environment.

The National Measurement Laboratory, Government Chemist and MHRA, three critical national functions of science and safety, brought together in a purpose-designed laboratory facility for the first time

Biosearch Technologies, signs MoU with Korea-based Genolution to integrate LGC’s sbeadex™ Lightning chemistry into the NX-Duo automated platform.

LGC Group opens its new Organic Chemistry Synthesis Centre of Excellence in Vaughan, Ontario, following a CAD $100 million investment.

LGC Group and Dynamic Devices announce their strategic partnership to enhance genomic solutions

LGC Board appoints Joydeep Goswami as President & Chief Executive

LGC’s leadership confirms that trading is in line with expectations, with positive momentum expected to continue through the second half of the year to 31 March 2025.

LGC acquires DiaMex to drive innovation and choice for core laboratory customers: Acquisition complements LGC’s serology and molecular quality control portfolio and enhances choice of products from a single supplier